Prostate Cancer - Results from #21060

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: Results from a systematic review and meta-analysis - Abstract May 6, 2014

Laparoscopic sentinel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinoma: A prospective study of 200 patients - Abstract May 6, 2014

Aspirin use and the risk of prostate cancer: A meta-analysis of 24 epidemiologic studies - Abstract May 6, 2014

Extended salvage pelvic lymph node dissection in patients with recurrent prostate cancer - Abstract May 6, 2014

The Prostate Health Index: A new test for the detection of prostate cancer - Abstract May 6, 2014

MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer - Abstract May 6, 2014

Is there an anti-androgen withdrawal syndrome for enzalutamide? - Abstract May 6, 2014

External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone - Abstract May 6, 2014

Factors influencing disease progression of prostate cancer under active surveillance: A McGill University Health Center Cohort - Abstract May 6, 2014

A phase II, randomized, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue in prostate cancer patients receiving LHRH-agonist therapy - Abstract May 6, 2014

Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy - Abstract May 6, 2014

Pretreatment tables predicting pathologic stage of locally advanced prostate cancer - Abstract May 6, 2014

Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions - Abstract May 6, 2014

Evaluation of On-Board kV cone beam computed tomography-based dose calculation with deformable image registration using Hounsfield unit modifications - Abstract May 6, 2014

Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions - Abstract May 5, 2014

Partner's perspective on long-term sexual dysfunction after prostate cancer treatment - Abstract May 5, 2014

Focal therapy-a new era in the treatment of prostate cancer - Abstract May 5, 2014

Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society - Abstract May 2, 2014

Biopsy criteria for determining appropriateness for active surveillance in the modern era - Abstract May 2, 2014

Model predictive control for optimally scheduling intermittent androgen suppression of prostate cancer - Abstract May 2, 2014

Page 1054 of 1457